World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 11 February 2019
Main ID:  ISRCTN56463078
Date of registration: 01/06/2018
Prospective Registration: Yes
Primary sponsor: Montreal Heart Institute Research Center
Public title: Validation study of a delirium detection tool completed by families
Scientific title: Evaluation of the psychometric properties of a delirium detection tool completed by families in cardiology
Date of first enrolment: 18/06/2018
Target sample size: 100
Recruitment status: Recruiting
URL:  http://isrctn.com/ISRCTN56463078
Study type:  Observational
Study design:  Validation study (Screening)  
Phase: 
Countries of recruitment
Canada
Contacts
Name: Tanya    Mailhot
Address:  Montreal Heart Institute 5000 Belanger Street, #S-2490 H1T 1C8 Montreal Canada
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. The family caregiver had to identify as a family caregiver (spouse, child, other family, friend) of an inpatient
2. Report having regular contact before hospitalization (= once a week). In the literature, this frequency of interaction was considered sufficient for the family member to report the usual cognitive and functional state of the patient, a knowledge necessary to be able to identify changes (Martins et al., 2014; Steis et al., 2012)
3. Have visited the patient at the hospital at least twice
4. Have the capacity to provide informed consent
5. 18 years old or older
6. Understand and read French
7. The hospitalized patient had to have the ability to provide informed consent or have a legal representative if their cognitive functioning was altered and present a stable clinical condition, allowing the evaluation of delirium using a questionnaire such as FAMCAM

Exclusion criteria: Does not meet inclusion criteria

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Delirium
Mental and Behavioural Disorders
Delirium, unspecified
Intervention(s)
The original English version of the FAM-CAM was translated and culturally adapted to French for Quebec, Canada with the method suggested by Sousa and Rojjanasrirat (2011). The process included obtaining the copyright clearance from the author for use and translation; double forward and backward translations; expert committee decision making and assessment of degree of clarity of the translated version by members of the population. Following this a validation study was performed using the French FAM-CAM. There is no follow-up planned in this study.
Primary Outcome(s)
The sensitivity and specificity of the French FAM-CAM compared with the reference standard (medical diagnosis according to DSM-5 criteria)
Secondary Outcome(s)

1. The sensitivity and specificity of the French FAM-CAM compared with delirium defined from a set of keywords associated with delirium (encephalopathy, confusion, agitation, hallucination, somnolence, haldol [Puelle et al., 2015]) and with scores on the Confusion Assessment Method (CAM)
2. The FAMCAM’s predictive value compared with the reference standard using a ROC curve
3. The reliability of the FAM-CAM compared with the CAM
Secondary ID(s)
ICM 2019-2426
Source(s) of Monetary Support
Montreal Heart Institute Foundation
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Montreal Heart Institute Ethics Board - approval pending
Results
Results available: Yes
Date Posted:
Date Completed: 15/06/2019
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history